(Medical Xpress)—Elderly patients with advanced non small cell lung cancer (NSCLC) who developed a rash within 28 days of receiving the targeted drug erlotinib (Tarceva) survived on average 6.2 months, c ...
Cancer Oct 17, 2012 | not rated yet | 0
Researchers from Mount Sinai School of Medicine have identified a six-gene signature that can be used in a test to predict survival in men with aggressive prostate cancer, according to new research published in the October ...
Cancer Oct 10, 2012 | not rated yet | 0
Scientists have discovered two separate genetic 'signatures' for prostate cancer that appear to be able to predict the severity of the disease, leading to hopes that in future, accuracy of prognosis and treatment of the disease ...
Cancer Oct 08, 2012 | 5 / 5 (1) | 0 |
(Medical Xpress)—Australian researchers have given hope to patients with advanced melanoma by showing that a new drug targeting a common mutation in melanoma successfully shrank tumours that had spread to the brain.
Cancer Oct 08, 2012 | not rated yet | 0 |
A new drug treatment could offer hope to patients with advanced colorectal cancer who were intolerant of or did not respond to standard treatments, according to an article published in the Lancet Oncology.
Cancer Aug 27, 2012 | not rated yet | 0
Results of a phase 2 randomised trial for patients with advanced differentiated thyroid cancer (DTC) show that those treated with the oral targeted agent vandetanib survived without the disease getting worse for almost twice ...
Cancer Aug 13, 2012 | not rated yet | 0
A new method of delivering a commonly used breast cancer drug could result in considerably less time spent in hospital for some women undergoing breast cancer treatment, according to the results of a Phase 3 trial published ...
Cancer Aug 08, 2012 | not rated yet | 0
Researchers at The University of Nottingham have identified three sets of genetic markers that could potentially pave the way for new diagnostic tools for a deadly type of brain tumour that mainly targets children.
Cancer Jun 15, 2012 | 5 / 5 (1) | 0 |
Scientists have discovered that a simple blood test could lead to better diagnosis and treatment for early-stage breast cancer patients, according to an Article published Online First in The Lancet Oncology.
Cancer Jun 05, 2012 | not rated yet | 0
The global cancer burden is set to surge more than 75% by 2030, according to new research published Online First in the Lancet Oncology. The rise is predicted to be even larger in the developing world, with the poorest countr ...
Cancer May 31, 2012 | 5 / 5 (2) | 0 |
Infectious agents cause around 2 million new cancer cases a year worldwide, of which 80% occur in less developed regions, according to new estimates published Online First in The Lancet Oncology. Of the 7.5 million deaths ...
Cancer May 08, 2012 | not rated yet | 0
Only clinically qualified medical physicists should be allowed to work in hospitals to avoid dangerous errors
In a Comment linked to The Lancet Physics Series, Dr Ahmed Meghzifene (Division of Human Health, International Atomic Energy Agency, Vienna, Austria) cautions that only physicists with the correct clinical training should ...
Other Apr 17, 2012 | not rated yet | 0
Having Huntington's disease or other 'polyQ' diseases protects against cancer, suggesting common genetic mechanism
Having Huntington's disease or other diseases known as polyglutamine (polyQ) diseases reduces a person's risk of getting cancer, suggesting a common genetic mechanism, concludes an Article published Online First by The Lancet On ...
Cancer Apr 11, 2012 | not rated yet | 0
(HealthDay) -- For some patients with advanced melanoma and brain metastases, ipilimumab is active, according to the results of a phase 2 study published online March 27 in The Lancet Oncology.
Cancer Mar 27, 2012 | not rated yet | 0
The under-reporting of the possible side effects of heart damage from cancer drugs puts patients at an increased risk for heart failure, according to two researchers at the Stanford University School of Medicine.
Cancer Mar 26, 2012 | 4 / 5 (1) | 0 |